» Articles » PMID: 11819493

A DNA Delivery System Containing Listeriolysin O Results in Enhanced Hepatocyte-directed Gene Expression

Overview
Specialty Gastroenterology
Date 2002 Jan 31
PMID 11819493
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

AIM:To determine whether incorporation of the pH dependent bacterial toxin listeriolysin O (LLO) into the DNA carrier system could increase the endosomal escape of internalized DNA and result gene expression.METHODS:A multi component delivery system was prepared consisting of asialoglycoprotein (ASG), poly L-lysine(PL), and LLO.Two marker genes, luciferase and beta galactosidase in plasmids were complexed and administered in vitro to Huh7(ASG receptor (+) and SK Hep1(ASG receptor (-) cells. Purity, hemolytic activity, gene expression, specificity, and toxicity were evaluated.RESULTS:An LLO containing conjugate retained cell target-ing specificity and membranolytic activity. In ASG receptor (+) cells,luciferase gene expression was enhanced by more than 7 fold over that of conjugates without the incorporation of listeriolysin O. No significant expression occurred in ASG receptor (-) cells. Enhancement of betagalactosidase gene expression was less, but still significantly increased over controls. There was no detectable toxicity at concentrations shown to be effective in transfection studies.CONCLUSIONS:ASOR-PL can be coupled to LLO using disulfide bonds, and successfully target and increase the gene expression of foreign DNA.

Citing Articles

Biopolymer-based Carriers for DNA Vaccine Design.

Franck C, Fanslau L, Bistrovic Popov A, Tyagi P, Fruk L Angew Chem Int Ed Engl. 2020; 60(24):13225-13243.

PMID: 32893932 PMC: 8247987. DOI: 10.1002/anie.202010282.


Application of advances in endocytosis and membrane trafficking to drug delivery.

Ju Y, Guo H, Edman M, Hamm-Alvarez S Adv Drug Deliv Rev. 2020; 157:118-141.

PMID: 32758615 PMC: 7853512. DOI: 10.1016/j.addr.2020.07.026.


Antigen delivery format variation and formulation stability through use of a hybrid vector.

Beitelshees M, Hill A, Li Y, Chen M, Ahmadi M, Smith Jr R Vaccine X. 2019; 1:100012.

PMID: 31384734 PMC: 6668244. DOI: 10.1016/j.jvacx.2019.100012.


Journey to the Center of the Cell: Current Nanocarrier Design Strategies Targeting Biopharmaceuticals to the Cytoplasm and Nucleus.

Munsell E, Ross N, Sullivan M Curr Pharm Des. 2015; 22(9):1227-44.

PMID: 26675220 PMC: 4792758. DOI: 10.2174/1381612822666151216151420.


Distribution and anti-HBV effects of antisense oligodeoxynucleotides conjugated to galactosylated poly-L-lysine.

Zheng S, Zhong S, Zhang J, Chen F, Ren H, Deng C World J Gastroenterol. 2003; 9(6):1251-5.

PMID: 12800234 PMC: 4611794. DOI: 10.3748/wjg.v9.i6.1251.


References
1.
Wagner E, Plank C, Zatloukal K, Cotten M, Birnstiel M . Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proc Natl Acad Sci U S A. 1992; 89(17):7934-8. PMC: 49829. DOI: 10.1073/pnas.89.17.7934. View

2.
Wu C, Wilson J, Wu G . Targeting genes: delivery and persistent expression of a foreign gene driven by mammalian regulatory elements in vivo. J Biol Chem. 1989; 264(29):16985-7. View

3.
Feng M, Jackson Jr W, Goldman C, Rancourt C, Wang M, Dusing S . Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector. Nat Biotechnol. 1997; 15(9):866-70. DOI: 10.1038/nbt0997-866. View

4.
Schlegel R, Wade M . Biologically active peptides of the vesicular stomatitis virus glycoprotein. J Virol. 1985; 53(1):319-23. PMC: 255044. DOI: 10.1128/JVI.53.1.319-323.1985. View

5.
Geoffroy C, Gaillard J, ALOUF J, Berche P . Purification, characterization, and toxicity of the sulfhydryl-activated hemolysin listeriolysin O from Listeria monocytogenes. Infect Immun. 1987; 55(7):1641-6. PMC: 260571. DOI: 10.1128/iai.55.7.1641-1646.1987. View